Background

Whether stem cells can regenerate cardiomyocytes after heart damage has long been a topic of interest in the biomedical field. In the early 2000s, attempts to treat cardiomyocytes with stem cells gained momentum, and the academic community was excited. In particular, a genetic fate-mapping study by Professor Richard T. Lee's research team at Harvard Medical School, published in the international journal Nature Medicine in 2007, is considered a milestone in this field. The paper experimentally demonstrated the hypothesis that stem cells present in the adult mammalian heart differentiate into cardiomyocytes after myocardial infarction (MI). The adult mammalian heart was previously thought to be incapable of self-regeneration. Therefore, the discovery that stem cells supply new cells was considered a paradigm-shifting achievement. However, when subsequent researchers reproduced the experiments in a similar manner, conflicting evidence emerged. The conclusion that direct division of existing cardiomyocytes is the primary mechanism of regeneration became more prevalent than the role of stem cells. As a result, the debate surrounding the actual mechanisms of cardiomyocyte regeneration continues to this day.

Key Findings

On August 12, 2026, the editorial board of Nature Medicine issued an official expression of concern regarding the 2007 paper by Professor Lee's team. According to the editorial board, the paper contained Western blot and fluorescence microscopy images that raised suspicions of duplication and compromised data integrity. Specifically, it was found that some images in Figure 1b, which showed '7-dose GFP' and '14-dose GFP' under different drug administration conditions, overlapped. The same duplication pattern was also observed in the separated fluorescence channels. In addition, the images of 'MI boundary GFP' and 'pressure overload GFP' in Figure 3a, which evaluated the heart damage model, were also found to partially overlap. This raised concerns that data from different experimental conditions had been duplicated and reused. In response, the majority of the authors, including Dr. Patrick C. H. Hsieh, co-first author and professor at National Cheng Kung University in Taiwan, and Professor Lee, the corresponding author, submitted explanations and accepted the editorial board's action. The authors stated that they could not retrieve the original data for Figure 1b due to the 19 years that had passed since the publication of the paper. However, they explained that the duplication issue in Figure 3a was a simple editing error that occurred during the preparation of the printed version, where adjacent fields of view within the MI model were cropped and rotated, resulting in an overlap. One of the co-authors of the paper, Professor Jeffrey Robbins, has already passed away, and Dr. Joseph Gannon, another author, did not respond to the publisher's request for confirmation.

Significance and Prospects

Academics believe that this expression of concern has significantly damaged the credibility of heart regeneration research in general. It shows that the early mechanisms of heart regeneration, which were established based on genetic fate-mapping techniques, were based on uncertain foundational data. Although the authors claim that it was a simple mistake or data loss due to the passage of time, the flaws found in a paper that shook the foundations of regenerative medicine have raised the level of scientific research ethics and data transparency. As a result, subsequent studies in the field of heart regeneration will have to undergo a more rigorous data verification process. In particular, with the development of artificial intelligence (AI)-based image analysis tools, the integrity verification of previously published academic papers is expected to gain further momentum. Furthermore, regulatory agencies and pharmaceutical companies are beginning to require more stringent original data comparison procedures when planning clinical trials based on preclinical data.